Covaxin is effective against the new variant of COVID-19 that was traced in the UK, an ICMR study has said. "Covaxin, developed by Bharat Biotech with ICMR, has equivalent immunogenicity against the UK-variant and %3D circulating strains of SARS-COV-2 in India," tweeted ICMR. "It's reassuring the vaccine can work against the new UK variant," said ICMR Director General Dr Balram Bhargava. Continue...
Covaxin is effective against the new variant of COVID-19 that was traced in the UK, an ICMR study has said. "Covaxin, developed by Bharat Biotech with ICMR, has equivalent immunogenicity against the UK-variant and %3D circulating strains of SARS-COV-2 in India," tweeted ICMR. "It's reassuring the vaccine can work against the new UK variant," said ICMR Director General Dr Balram Bhargava. Continue...
I just loved the way to discover the unknown or partially known things of our planet !! Just loved it!! Keep it up!! #adventure 🤘
ReplyDelete